Inogen (INGN) Enterprise Value Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.52% |
| Dec 31, 2025 | 20.11% |
| Sep 30, 2025 | 20.95% |
| Jun 30, 2025 | 18.19% |
| Mar 31, 2025 | 18.14% |
| Dec 31, 2024 | 21.00% |
| Sep 30, 2024 | 21.04% |
| Jun 30, 2024 | 25.95% |
| Mar 31, 2024 | 19.90% |
| Dec 31, 2023 | 17.79% |
| Sep 30, 2023 | 47.09% |
| Jun 30, 2023 | 7.37% |
| Mar 31, 2023 | 42.90% |
| Dec 31, 2022 | 0.50% |
| Sep 30, 2022 | -11.08% |
| Jun 30, 2022 | -42.65% |
| Mar 31, 2022 | -48.43% |
| Dec 31, 2021 | -6.87% |
| Sep 30, 2021 | -3.07% |
| Jun 30, 2021 | -6.25% |
| Mar 31, 2021 | -71.31% |
| Dec 31, 2020 | -44.13% |
| Sep 30, 2020 | -37.91% |
| Jun 30, 2020 | -51.58% |
| Mar 31, 2020 | -24.94% |
| Dec 31, 2019 | -22.45% |
| Sep 30, 2019 | -13.67% |
| Jun 30, 2019 | 7.75% |
| Mar 31, 2019 | 6.18% |
| Dec 31, 2018 | -39.99% |
| Sep 30, 2018 | -55.18% |
| Jun 30, 2018 | -46.66% |
| Mar 31, 2018 | 8.78% |
| Dec 31, 2017 | -4.09% |
| Sep 30, 2017 | -14.39% |
| Jun 30, 2017 | 3.80% |
| Mar 31, 2017 | -21.51% |
| Dec 31, 2016 | -45.54% |
| Sep 30, 2016 | -100.11% |
| Jun 30, 2016 | -79.17% |
| Mar 31, 2016 | -41.70% |
| Dec 31, 2015 | -40.58% |